J. Van Bocxlaer

Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels?

Abstract As drug instability and redistribution are factors known to affect the interpretation of post-mortem blood levels, we questioned whether post-mortem vitreous humour concentrations could be useful as predictors for the MDMA load at the time of death. In a first series of in vivo experiments using rabbits, 3,4-methylenedioxy-methamphetamine (MDMA) concentrations in plasma, blood and vitreous humour were studied as a function of time after intravenous (iv) administration of MDMA. Equilibration between the vascular compartment and vitreous humour was attained about 1 h after iv MDMA administration. In a second series of experiments, the post-mortem stability of MDMA in vitreous humour in relation to ambient temperature was investigated. Post-mortem MDMA concentrations in vitreous humour were closer to the ante-mortem blood levels when compared to cardiac blood samples. These preliminary investigations in the rabbit model indicate that measurements of vitreous humour concentrations could also be of interest for predicting the blood concentration at the time of death in humans.

Pattern recognition techniques screening for drugs of abuse with gas chromatography–Fourier transform infrared spectroscopy☆

As many drugs of abuse are relatively volatile substances, gas chromatography-mass spectrometry (GC-MS), and more recently gas chromatography-Fourier transform infrared spectroscopy (GC-FTIR) became the most powerful techniques applied for their identification. We are presenting a combination of pattern recognition techniques discriminating illicit amphetamines according to the substitution pattern associated with the psychotropic activity (stimulants and hallucinogens) for which they are abused, and with the corresponding level of health hazard. As we determined, GC-FTIR provides the best selectivity in identifying the structural features associated with the full constellation of pharmacological effects of amphetamines. The toxicological questions to be answered and the spectroscopic features enabling the screening based on soft independent modeling of class analogy (SIMCA) are discussed. The accuracy, sensitivity and selectivity of the system recommend its use for automating the investigations of illicit drugs for epidemiological, clinical, administrative and forensic purposes. As opposed to the traditional tests screening for drugs of abuse, the system may also be applied as a broad-spectrum screening test. The extent to which the output of a query for amphetamines may be used for assessing the class identity of a negative (i.e. other hallucinogens or stimulants, sympathomimetic amines, narcotics and precursors) was determined by a systematic principal component analysis (PCA). The basic information is summarized in tables according to the category or class of compounds found suitable for screening.

Quantitative determination of glycopyrrolate in human plasma by liquid chromatography-electrospray ionization mass spectrometry: the use of a volatile ion-pairing agent during both liquid-liquid extraction and liquid chromatography.

The work presented here deals with the development of a quantitative tool for the determination of the quaternary ammonium anticholinergic glycopyrrolate in human plasma samples. Mepenzolate was used as an internal standard. The plasma samples were subjected to a suitable sample clean-up consisting of a simple and relatively fast, two step liquid-liquid ion-pair extraction procedure. The chromatography, using the same volatile ion-pair reagent heptafluorobutyric acid (HFBA), takes only 10 min. Relative standard deviation of retention times was never above 2.26% (n=36). The method was fully validated based on the US FDA Bioanalytical Method Validation Guidance for Industry. As such, a quantitative ESI-LC-MS(/MS) (TOF mass spectrometry) method was optimized for the absolute quantification of glycopyrrolate in human plasma in a concentration range from 0.101 to 101 ng/mL using a quadratic calibration function (R(2)=0.9995), y=-2.21 x 10(-4) (+/-3.93 x 10(-5))xx(2)+5.85 x 10(-2) (+/-5.27 x 10(-3))xx+4.08 x 10(-3) (+/-4.82 x 10(-4)). For the three QC concentrations (QC(1) 0.252, QC(2) 2.52, and QC(3) 25.2ng/mL) and the LLOQ (0.101 ng/mL), total precision was under 20% (18.0% (n=6) at the LLOQ) and maximum accuracy was 112% (88.9% for the LLOQ, n=6). Absolute matrix effect (maximum 133%+/-9.59, n=3), absolute recovery (better than 41.8%+/-2.22, n=3), relative (inter-subject) matrix effect (maximum 10.9%+/-1.45, n=4) and process efficiency (better than 45.2%+/-5.74, n=3) too were assessed at the 3 QC concentrations.

Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents*

Two new generation carbon dioxide absorbents, DrägerSorb® Free and Amsorb® Plus, were studied in vitro for formation of compound A or carbon monoxide, during minimal gas flow (500 ml.min−1) with sevoflurane or desflurane. Compound A was assessed by gas chromatography/mass spectrometry and carbon monoxide with continuous infrared spectrometry. Fresh and dehydrated absorbents were studied. Mean (SD) time till exhaustion (inspiratory carbon dioxide concentration ≥ 1 kPa) with fresh absorbents was longer with DrägerSorb® Free (1233 (55) min) than with Amsorb® Plus (1025 (55) min; p < 0.01). For both absorbents, values of compound A were < 1 ppm and therefore below clinically significant levels, but were up to 0.25 ppm higher with DrägerSorb® Free than with Amsorb® Plus. Using dehydrated absorbents, values of compound A were about 50% lower than with fresh absorbents and were identical for DrägerSorb® Free and Amsorb® Plus. With dehydrated absorbents, no detectable carbon monoxide was found with desflurane.

Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens

The effects of the mycotoxin T-2 on hepatic and intestinal drug-metabolizing enzymes (cytochrome P450) and drug transporter systems (MDR1 and MRP2) in poultry were investigated during this study. Broiler chickens received either uncontaminated feed, feed contaminated with 68μg/kg or 752μg/kg T-2 toxin. After 3weeks, the animals were euthanized and MDR1, MRP2, CYP1A4, CYP1A5 and CYP3A37 mRNA expression were analyzed using qRT-PCR. Along the entire length of the small intestine no significant differences were observed. In the liver, genes coding for CYP1A4, CYP1A5 and CYP3A37 were significantly down-regulated in the group exposed to 752μg/kg T-2. For CYP1A4, even a contamination level of 68μg/kg T-2 caused a significant decrease in mRNA expression. Expression of MDR1 was not significantly decreased in the liver. In contrast, hepatic MRP2 expression was significantly down-regulated after exposure to 752μg/kg T-2. Hepatic and intestinal microsomes were prepared to test the enzymatic activity of CYP3A. In the ileum and liver CYP3A activity was significantly increased in the group receiving 752μg/kg T-2 compared to the control group. The results of this study show that drug metabolizing enzymes and drug transporter mechanisms can be influenced due to prolonged exposure to relevant doses of T-2.

Exploratory analysis for the automated identification of amphetamines from vapour-phase FTIR spectra

An exploratory analysis was performed in order to evaluate the feasibility of building an expert system automating the identification of the basic skeleton of amphetamines necessary in the investigation of drugs of abuse for epidemiological, clinical, and forensic purposes. Emphasis was placed on the selection of the sample preparation and data processing techniques yielding the best differentiation and recognition of the structural patterns of amphetamines. Discrimination between amphetamine analogues and nonamphetamines has been put in evidence. More accurate discrimination among amphetamine analogues according to substitution patterns was obtained with spectra of amphetamine analogues, rather than with those of their HFB-derivatives. The automated recognition of substitution patterns influencing the intensity of the pharmacological activity seems also feasible, especially in the case of the ring nonsubstituted amphetamines.

Hot-melt extrusion of polyvinyl alcohol for oral immediate release applications.

The primary purpose of this study was to process partially hydrolyzed PVOH grades (degree of hydroxylation (DH): 33-88%) via HME and to evaluate them as carrier for oral immediate release dosage forms in order to improve the release rate of poorly water soluble drugs (i.e., HCT and CEL) via the formulation of solid dispersions. PVOH grades (DH >70%) were able to solubilize HCT and CEL up to 15%, but required higher extrusion temperature, due to the crystalline nature of PVOH. The highest drug release rate was observed from hot-melt extruded PVOH samples with a high DH. While drug release from extrudates consisting of PVOH with a low DH was affected by ionic strength, there was no influence of pH and ionic strength on HCT release from PVOH samples with a higher DH. However, PVOH (DH >70%) required higher extrusion temperatures, which could hamper its application for thermosensitive drugs. Therefore, the secondary purpose was to investigate the effect of sorbitol, a water-soluble plasticizer, on the thermal properties of hot-melt extruded PVOH (DH >70%). The melting of PVOH/sorbitol mixture was required to establish molecular interactions between PVOH and sorbitol. These molecular interactions were reflected in the HME behavior: whereas an extrusion temperature of 180 °C was necessary to process physical mixtures of PVOH (DH >70%) and sorbitol, only 140 °C was necessary during re-extrusion (after quench cooling and cryomilling) of the PVOH/sorbitol mixture. In addition, the in vitro and in vivo dug release of plasticized PVOH was examined; whereas the CEL/PVO/sorbitol system was able to maintain supersaturation during in vitro dissolution (0.1N HCl) compared to Celebrex(®), the in vivo pharmacokinetic parameters (AUC0-24h, Cmax and Tmax) were highly comparable.

Identification of novel illicit amphetamines from vapor-phase FTIR spectra : a chemometrical solution

A computer-aided procedure automating the identification of illicit amphetamine analogs eluting from a gas chromatograph coupled to a Fourier transform infrared spectrometer is presented. The expert system discriminates novel amphetamines from other classes of drugs of abuse normally screened in illicit tablets or powders. The main analytical advantages of the system over the automated procedures dedicated to general unknown analysis are the objectivity and the accuracy in predicting the class identity of the compound (i.e. stimulant, hallucinogen) when the reference spectrum is not present in the spectral library. The expert system uses quantitative thresholds defining the similarity of the unknown to the classes of illicit amphetamines and checks the presence of the molecular skeletons associated with different psychotropic effects of amphetamines. The challenge in building the system was the fuzziness of vapor-phase Fourier transform infrared spectrometer spectra of low-weight molecules such as amphetamines. This paper emphasizes the chemometrical techniques found most appropriate for modeling such spectral behavior. An exploratory (principal component) analysis indicated the sample preparation and the feature weight function yielding the best input for the knowledge base. The class identity of a compound was assigned using Soft Independent Modeling of Class Analogy. A rule-based decision system was implemented to enhance the accuracy in identity assignment. The flow diagram optimizing the knowledge base content of each model is presented. Finally, up to 81.13% (out of 159 tested compounds) were classified with a 5% confidence level. The total correct classification rate was 93.93%, for a yield of 96.30% true positive amphetamines.

Chemometric detection of thermally degraded samples in the analysis of drugs of abuse with gas chromatography-Fourier-transform infrared spectroscopy

We present a chemometric procedure for the identification of the reference standard chromatographic peak in cases where the GC-FTIR analysis of commercial standards results in the appearance of more than one peak in the GC chromatogram. The procedure has been designed for phenethylamines, which represent the class with the largest number of individual molecules on the illicit drug market, and which are abused for their stimulant and/or hallucinogenic effects. The similarity between their vapor-phase FTIR spectra was modeled using principal component analysis (PCA), and class identity was assigned on the basis of soft independent modeling of class analogy (SIMCA). Additional peaks could be assigned to impurities in the standards, but most often they were artifacts formed during the GC-FTIR analysis of thermolabile or chemically unstable compounds. The latter case is illustrated by the identification of the reference standard chromatographic peak and FTIR spectrum of the potent psychotropic amphetamine derivative N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB), and by the elucidation of the chemical changes that occur in the molecule of MBDB due to thermal degradation.

The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs

Mycotoxins are toxic metabolites produced by fungi that readily colonize crops. After ingestion, these mycotoxins can compromise intestinal health, and once entering the blood stream, even affect the liver and its metabolizing enzymes. It was therefore the aim of the present study to investigate the effect of T-2 toxin, an emerging and potent Fusarium mycotoxin, on the enzymatic activity of cytochrome P4503A (CYP3A) metabolizing enzymes in the liver of pigs. In addition, a yeast-derived feed additive that claims to bind T-2 toxin was included in the study to evaluate its efficacy. Our results demonstrated that a 14-days intake of T-2 toxin contaminated feed at a dose of 903 μg/kg feed, whether or not combined with the mycotoxin binder, results in a substantial inhibition of the CYP3A activity in the liver of pigs. This result may be of importance for animal health, the pharmacokinetics and the withdrawal time of drugs that are substrate of CYP3A enzymes, and consequently can be a threat for public health with respect to tissue residues of these drugs.